Sangamo BioSciences, Inc. (SGMO) Presents New Data From In Vivo Protein Replacement Platform for Development of ZFP Therapeutics® for Monogenic Diseases
5/20/2013 10:27:03 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic®, SB-728-T
5/15/2013 9:25:40 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation at the Bank of America (BAC) Merrill Lynch 2013 Health Care Conference
5/10/2013 6:42:02 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Reports First Quarter 2013 Financial Results
5/9/2013 6:33:41 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces First Quarter 2013 Conference Call and Webcast
5/2/2013 6:39:01 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation at the Needham Healthcare Conference
4/25/2013 7:19:10 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation at Regen Med Investor Day
4/11/2013 9:35:58 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Presents New Clinical Data at CROI 2013 Demonstrating Persistent Immune System Improvements After Treatment With ZFN Therapeutic® SB-728-T
3/6/2013 10:02:55 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation at the Barclays Global Healthcare Conference
3/6/2013 6:43:10 AM
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation at 33rd Annual Cowen and Company Health Care Conference
2/28/2013 6:38:50 AM
More...
|
|